Effortless Weight Loss. Quiet The Food Noise.

Yes. GLP-1 medications (including Semaglutide and Tirzepatide) are prescription-only medications in the United States. All telehealth programs listed on ShrinkThatBelly.com include an evaluation by a US board-certified doctor or licensed medical provider who writes the prescription if you meet medical eligibility criteria.

Brand-name medications (like Ozempic®, Wegovy®, and Mounjaro®) are produced by commercial pharmaceutical manufacturers and often cost over $900–$1,300/month without insurance coverage. Compounded Semaglutide and Tirzepatide are prepared by state-licensed 503A or 503B compounding pharmacies to help meet patient demand during national FDA drug shortages, offering identical active pharmaceutical ingredients at significantly lower out-of-pocket costs ($179–$299/mo).

For the verified programs highlighted on our site, the monthly fee is all-inclusive: it covers your initial medical questionnaire evaluation, ongoing clinical messaging, the prescribed medication, sterile administration supplies (syringes/pads), and priority temperature-controlled shipping.

Generally, medical guidelines recommend GLP-1 therapy for adults with a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition (such as hypertension or elevated cholesterol). Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) are not eligible.